Likewise, MMP-12 could be a benign prognosis index, because the concentrations of MMP-12 in WF from the breast cancer patients with luminal subtypes tended to be higher than that with HER2 overexpression and basal subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.